Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2008 4
2009 4
2010 4
2011 4
2012 3
2013 5
2014 10
2015 11
2016 10
2017 5
2018 5
2019 4
2020 5
2021 7
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
A Series of PSMA-Targeted Near-Infrared Fluorescent Imaging Agents.
Chen Y, Minn I, Rowe SP, Lisok A, Chatterjee S, Brummet M, Banerjee SR, Mease RC, Pomper MG. Chen Y, et al. Among authors: mease rc. Biomolecules. 2022 Mar 5;12(3):405. doi: 10.3390/biom12030405. Biomolecules. 2022. PMID: 35327597 Free PMC article.
Pharmacodynamic measures within tumors expose differential activity of PD(L)-1 antibody therapeutics.
Kumar D, Mishra A, Lisok A, Kureshi R, Shelake S, Plyku D, Sen R, Doucet M, De Silva RA, Mease RC, Forde PM, Jaffee EM, Desai P, Ganguly S, Gabrielson E, Vaidya D, Spangler JB, Nimmagadda S. Kumar D, et al. Among authors: mease rc. Proc Natl Acad Sci U S A. 2021 Sep 14;118(37):e2107982118. doi: 10.1073/pnas.2107982118. Proc Natl Acad Sci U S A. 2021. PMID: 34508005 Free PMC article.
An Improved 211At-Labeled Agent for PSMA-Targeted α-Therapy.
Mease RC, Kang CM, Kumar V, Banerjee SR, Minn I, Brummet M, Gabrielson KL, Feng Y, Park A, Kiess AP, Sgouros G, Vaidyanathan G, Zalutsky MR, Pomper MG. Mease RC, et al. J Nucl Med. 2022 Feb;63(2):259-267. doi: 10.2967/jnumed.121.262098. Epub 2021 Jun 4. J Nucl Med. 2022. PMID: 34088772 Free PMC article.
Synthesis and preliminary evaluation of 211At-labeled inhibitors of prostate-specific membrane antigen for targeted alpha particle therapy of prostate cancer.
Vaidyanathan G, Mease RC, Minn I, Choi J, Chen Y, Shallal H, Kang CM, McDougald D, Kumar V, Pomper MG, Zalutsky MR. Vaidyanathan G, et al. Among authors: mease rc. Nucl Med Biol. 2021 Mar-Apr;94-95:67-80. doi: 10.1016/j.nucmedbio.2021.01.002. Epub 2021 Jan 23. Nucl Med Biol. 2021. PMID: 33601187 Free PMC article.
Process validation, current good manufacturing practice production, dosimetry, and toxicity studies of the carbonic anhydrase IX imaging agent [111 In]In-XYIMSR-01 for phase I regulatory approval.
De Silva RA, Gorin MA, Mease RC, Minn I, Lisok A, Plyku D, Nimmagadda S, Allaf ME, Yang X, Sgouros G, Rowe SP, Pomper MG. De Silva RA, et al. Among authors: mease rc. J Labelled Comp Radiopharm. 2021 May 30;64(6):243-250. doi: 10.1002/jlcr.3906. Epub 2021 Mar 4. J Labelled Comp Radiopharm. 2021. PMID: 33576099 Free PMC article.
Prospective Evaluation of 18F-DCFPyL PET/CT in Detection of High-Risk Localized Prostate Cancer: Comparison With mpMRI.
Gaur S, Mena E, Harmon SA, Lindenberg ML, Adler S, Ton AT, Shih JH, Mehralivand S, Merino MJ, Wood BJ, Pinto PA, Mease RC, Pomper MG, Choyke PL, Turkbey B. Gaur S, et al. Among authors: mease rc. AJR Am J Roentgenol. 2020 Sep;215(3):652-659. doi: 10.2214/AJR.19.22042. Epub 2020 Jul 8. AJR Am J Roentgenol. 2020. PMID: 32755168 Free PMC article.
74 results